Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca PLC

http://www.astrazeneca.com

Latest From AstraZeneca PLC

Twitchy Times At GSK As Activist Investor Takes Big Stake

GlaxoSmithKline's market value has slipped in the past three years and the number of failures in the clinic have grown. The major's leadership will be casting nervous glances towards a major shareholder that has a reputation for aggressive restructuring calls.   

Strategy Leadership

A Whole New Year For Pharma: Macro Pressures Mount Heading Into Q1 Reporting

First quarter earnings preview: US drug pricing reform, an uncertain regulatory outlook and new focus on M&A are rising challenges that could put the industry's growth at risk.

Sales & Earnings FDA

GSK's ICOS Agonist Disappointment Another Setback For Anticancer Ambitions

GlaxoSmithKline has discontinued treatment with its ICOS agonist feladilimab in the Phase II INDUCE-3 trial upon the recommendation of the study’s data monitoring committee, another setback for the big pharma’s plans to become a major force in the cancer therapy area.

Cancer Clinical Trials

Supply Concerns As India Fast Tracks COVID-19 Vaccines Approved By Certain Regulators

In an unusual move prompted by an enormous second wave of infections, India is accelerating approvals for COVID-19 vaccines granted emergency use authorizations by other selected regulators or on the WHO’s emergency use list without a local bridging study. While this seems a prelude to permitting private sales, where will the supplies come from?

India Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Almirall Sofotec
    • AlphaCore Pharma
    • Amplimmune, Inc.
    • Ardea Biosciences, Inc.
    • Arrow Therapeutics
    • Aviron
    • Cellective Therapeutics, Inc.
    • Definiens
    • IntraBiotics Pharmaceuticals, Inc.
    • KuDOS Pharmaceuticals Ltd.
    • Medimmune
    • Novexel
    • Omthera Pharmaceuticals
    • Pearl Therapeutics
    • Spirogen Ltd.
    • U.S. Bioscience
    • Acerta Pharma
    • ZS Pharma
UsernamePublicRestriction

Register